Search

everythinglearnresearchcommunity

for

Search:↓

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

The 1298CC genotype in RA patients leads to higher methotrexate toxicity, while the 1298AA genotype results in better treatment response.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Using a call center to collect data in a trial for eye disease in diabetics led to high response rates and very little missing information.

Pimecrolimus cream is not effective for treating alopecia areata.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

The authors agree they didn't follow the original criteria strictly but found the Ottawa rule effective in all tested patients and suggest it might have wider use.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

COVID-19 may trigger alopecia areata, but more research is needed.

Pharmacists are key in choosing and guiding the safe use of topical corticosteroids for skin conditions.

Engineered exosomes show promise for improving wound healing but face challenges in clinical use.

Composite biodegradable biomaterials can improve diabetic wound healing but need more development for clinical use.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

Mupirocin ointment effectively treats feline acne.

Botulinum toxin is not effective for treating male hair loss.

Selenium deficiency caused symptoms in a child, which improved with selenium supplements.

Non-ablative and ablative fractional lasers helped hair growth in some cases without major side effects, but didn't work for all hair disorders.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.